Adverum Biotechnologies, Inc.: 10-Q filed 2017-08-08
What Adverum Biotechnologies, Inc. reported in its quarterly report filed 2017-08-08 (fiscal Q2 2017): 28 published measures, 74 facts as tagged in accession 0001564590-17-016588.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-08-08
- Fiscal period
- fiscal Q2 2017
- Accession
- 0001564590-17-016588 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Adverum Biotechnologies, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 208,579,000 | USD | |
| At 2016-12-31 | 234,583,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 16,399,000 | USD | |
| At 2016-12-31 | 18,983,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 192,180,000 | USD | |
| At 2016-12-31 | 215,600,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 39,523,000 | USD | |
| At 2016-12-31 | 222,170,000 | USD | |
| At 2016-06-30 | 241,302,000 | USD | |
| At 2015-12-31 | 221,348,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -11,430,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -27,529,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -61,660,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -77,052,000 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 732,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 1,126,000 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -225,444,000 | USD | |
| At 2016-12-31 | -197,915,000 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 3,798,000 | USD | |
| At 2016-12-31 | 4,169,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 4,139,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 6,903,000 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -12,093,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -28,681,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -61,882,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -77,390,000 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 199,641,000 | USD | |
| At 2016-12-31 | 225,274,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 8,313,000 | USD | |
| At 2016-12-31 | 9,896,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 1,125,000 | USD | |
| At 2016-12-31 | 1,474,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 12,556,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 29,606,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 62,189,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 77,962,000 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 8,492,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 17,553,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 7,955,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 15,410,000 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 43,201,786 | shares | |
| At 2016-12-31 | 41,805,009 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -403,000 | USD | |
| At 2016-12-31 | -7,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 7,442,000 | USD | |
| At 2016-12-31 | 6,763,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 3,644,000 | USD | |
| At 2016-12-31 | 2,594,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 5,000,000 | USD | |
| At 2016-12-31 | 5,000,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 140,000 | USD | |
| At 2016-12-31 | 140,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 369,000 | USD | |
| At 2016-12-31 | 386,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 2,223,000 | USD | |
| At 2016-12-31 | 2,218,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -11,620,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -27,925,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -61,664,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -77,036,000 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 4,064,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 12,053,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 5,114,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 13,432,000 | USD | 182 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 663,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 1,152,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 222,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 338,000 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 663,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 1,152,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 222,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 338,000 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | -334,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 646,000 | USD | 182 |
Inspect the source
- Entity
- Adverum Biotechnologies, Inc. / CIK 0001501756
- Captured
- 2026-09-21T17:19:30.277Z
- SEC response SHA-256
3e3f88b341f4a0ffa9ee013477a8ae8ec2c292f96270a497f1b280e9a59501b4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001501756.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))